Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.
Identifieur interne : 002805 ( PubMed/Curation ); précédent : 002804; suivant : 002806Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.
Auteurs : Stefan H E. Kaufmann [Allemagne] ; Andrew J. McmichaelSource :
- Nature medicine [ 1078-8956 ] ; 2005.
Descripteurs français
- KwdFr :
- Animaux, Essais cliniques comme sujet (législation et jurisprudence), Humains, Mycobacterium bovis (génétique), Mycobacterium bovis (immunologie), Mycobacterium tuberculosis (génétique), Mycobacterium tuberculosis (immunologie), Syndrome d'immunodéficience acquise (), Syndrome d'immunodéficience acquise (immunologie), Tuberculose (), Tuberculose (immunologie), Vaccins antituberculeux, Vaccins contre le SIDA.
- MESH :
- génétique : Mycobacterium bovis, Mycobacterium tuberculosis.
- immunologie : Mycobacterium bovis, Mycobacterium tuberculosis, Syndrome d'immunodéficience acquise, Tuberculose.
- législation et jurisprudence : Essais cliniques comme sujet.
- Animaux, Humains, Syndrome d'immunodéficience acquise, Tuberculose, Vaccins antituberculeux, Vaccins contre le SIDA.
English descriptors
- KwdEn :
- AIDS Vaccines, Acquired Immunodeficiency Syndrome (complications), Acquired Immunodeficiency Syndrome (immunology), Acquired Immunodeficiency Syndrome (prevention & control), Animals, Clinical Trials as Topic (legislation & jurisprudence), Humans, Mycobacterium bovis (genetics), Mycobacterium bovis (immunology), Mycobacterium tuberculosis (genetics), Mycobacterium tuberculosis (immunology), Tuberculosis (complications), Tuberculosis (immunology), Tuberculosis (prevention & control), Tuberculosis Vaccines.
- MESH :
- chemical : AIDS Vaccines, Tuberculosis Vaccines.
- complications : Acquired Immunodeficiency Syndrome, Tuberculosis.
- genetics : Mycobacterium bovis, Mycobacterium tuberculosis.
- immunology : Acquired Immunodeficiency Syndrome, Mycobacterium bovis, Mycobacterium tuberculosis, Tuberculosis.
- legislation & jurisprudence : Clinical Trials as Topic.
- prevention & control : Acquired Immunodeficiency Syndrome, Tuberculosis.
- Animals, Humans.
Abstract
Human immunodeficiency virus (HIV) and Mycobacterium tuberculosis annually cause 3 million and 2 million deaths, respectively. Last year, 600,000 individuals, doubly infected with HIV and M. tuberculosis, died. Since World War I, approximately 150 million people have succumbed to these two infections--more total deaths than in all wars in the last 2,000 years. Although the perceived threats of new infections such as SARS, new variant Creutzfeldt-Jakob disease and anthrax are real, these outbreaks have caused less than 1,000 deaths globally, a death toll AIDS and tuberculosis exact every 2 h. In 2003, 40 million people were infected with HIV, 2 billion with M. tuberculosis, and 15 million with both. Last year, 5 million and 50 million were newly infected with HIV or M. tuberculosis, respectively, with 2 million new double infections. Better control measures are urgently needed.
DOI: 10.1038/nm1221
PubMed: 15812488
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002805
Links to Exploration step
pubmed:15812488Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.</title>
<author><name sortKey="Kaufmann, Stefan H E" sort="Kaufmann, Stefan H E" uniqKey="Kaufmann S" first="Stefan H E" last="Kaufmann">Stefan H E. Kaufmann</name>
<affiliation wicri:level="1"><nlm:affiliation>Max Planck Institute for Infection Biology, Department of Immunology, Schumannstrasse 21-22, 10117 Berlin, Germany. kaufmann@mpiib-berlin.mpg.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Max Planck Institute for Infection Biology, Department of Immunology, Schumannstrasse 21-22, 10117 Berlin</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mcmichael, Andrew J" sort="Mcmichael, Andrew J" uniqKey="Mcmichael A" first="Andrew J" last="Mcmichael">Andrew J. Mcmichael</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15812488</idno>
<idno type="pmid">15812488</idno>
<idno type="doi">10.1038/nm1221</idno>
<idno type="wicri:Area/PubMed/Corpus">002805</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002805</idno>
<idno type="wicri:Area/PubMed/Curation">002805</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002805</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.</title>
<author><name sortKey="Kaufmann, Stefan H E" sort="Kaufmann, Stefan H E" uniqKey="Kaufmann S" first="Stefan H E" last="Kaufmann">Stefan H E. Kaufmann</name>
<affiliation wicri:level="1"><nlm:affiliation>Max Planck Institute for Infection Biology, Department of Immunology, Schumannstrasse 21-22, 10117 Berlin, Germany. kaufmann@mpiib-berlin.mpg.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Max Planck Institute for Infection Biology, Department of Immunology, Schumannstrasse 21-22, 10117 Berlin</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mcmichael, Andrew J" sort="Mcmichael, Andrew J" uniqKey="Mcmichael A" first="Andrew J" last="Mcmichael">Andrew J. Mcmichael</name>
</author>
</analytic>
<series><title level="j">Nature medicine</title>
<idno type="ISSN">1078-8956</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS Vaccines</term>
<term>Acquired Immunodeficiency Syndrome (complications)</term>
<term>Acquired Immunodeficiency Syndrome (immunology)</term>
<term>Acquired Immunodeficiency Syndrome (prevention & control)</term>
<term>Animals</term>
<term>Clinical Trials as Topic (legislation & jurisprudence)</term>
<term>Humans</term>
<term>Mycobacterium bovis (genetics)</term>
<term>Mycobacterium bovis (immunology)</term>
<term>Mycobacterium tuberculosis (genetics)</term>
<term>Mycobacterium tuberculosis (immunology)</term>
<term>Tuberculosis (complications)</term>
<term>Tuberculosis (immunology)</term>
<term>Tuberculosis (prevention & control)</term>
<term>Tuberculosis Vaccines</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Essais cliniques comme sujet (législation et jurisprudence)</term>
<term>Humains</term>
<term>Mycobacterium bovis (génétique)</term>
<term>Mycobacterium bovis (immunologie)</term>
<term>Mycobacterium tuberculosis (génétique)</term>
<term>Mycobacterium tuberculosis (immunologie)</term>
<term>Syndrome d'immunodéficience acquise ()</term>
<term>Syndrome d'immunodéficience acquise (immunologie)</term>
<term>Tuberculose ()</term>
<term>Tuberculose (immunologie)</term>
<term>Vaccins antituberculeux</term>
<term>Vaccins contre le SIDA</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>AIDS Vaccines</term>
<term>Tuberculosis Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term>
<term>Tuberculosis</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Mycobacterium bovis</term>
<term>Mycobacterium tuberculosis</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Mycobacterium bovis</term>
<term>Mycobacterium tuberculosis</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Mycobacterium bovis</term>
<term>Mycobacterium tuberculosis</term>
<term>Syndrome d'immunodéficience acquise</term>
<term>Tuberculose</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term>
<term>Mycobacterium bovis</term>
<term>Mycobacterium tuberculosis</term>
<term>Tuberculosis</term>
</keywords>
<keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>Clinical Trials as Topic</term>
</keywords>
<keywords scheme="MESH" qualifier="législation et jurisprudence" xml:lang="fr"><term>Essais cliniques comme sujet</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term>
<term>Tuberculosis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Humains</term>
<term>Syndrome d'immunodéficience acquise</term>
<term>Tuberculose</term>
<term>Vaccins antituberculeux</term>
<term>Vaccins contre le SIDA</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Human immunodeficiency virus (HIV) and Mycobacterium tuberculosis annually cause 3 million and 2 million deaths, respectively. Last year, 600,000 individuals, doubly infected with HIV and M. tuberculosis, died. Since World War I, approximately 150 million people have succumbed to these two infections--more total deaths than in all wars in the last 2,000 years. Although the perceived threats of new infections such as SARS, new variant Creutzfeldt-Jakob disease and anthrax are real, these outbreaks have caused less than 1,000 deaths globally, a death toll AIDS and tuberculosis exact every 2 h. In 2003, 40 million people were infected with HIV, 2 billion with M. tuberculosis, and 15 million with both. Last year, 5 million and 50 million were newly infected with HIV or M. tuberculosis, respectively, with 2 million new double infections. Better control measures are urgently needed.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15812488</PMID>
<DateCompleted><Year>2005</Year>
<Month>07</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1078-8956</ISSN>
<JournalIssue CitedMedium="Print"><Volume>11</Volume>
<Issue>4 Suppl</Issue>
<PubDate><Year>2005</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Nature medicine</Title>
<ISOAbbreviation>Nat. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.</ArticleTitle>
<Pagination><MedlinePgn>S33-44</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Human immunodeficiency virus (HIV) and Mycobacterium tuberculosis annually cause 3 million and 2 million deaths, respectively. Last year, 600,000 individuals, doubly infected with HIV and M. tuberculosis, died. Since World War I, approximately 150 million people have succumbed to these two infections--more total deaths than in all wars in the last 2,000 years. Although the perceived threats of new infections such as SARS, new variant Creutzfeldt-Jakob disease and anthrax are real, these outbreaks have caused less than 1,000 deaths globally, a death toll AIDS and tuberculosis exact every 2 h. In 2003, 40 million people were infected with HIV, 2 billion with M. tuberculosis, and 15 million with both. Last year, 5 million and 50 million were newly infected with HIV or M. tuberculosis, respectively, with 2 million new double infections. Better control measures are urgently needed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kaufmann</LastName>
<ForeName>Stefan H E</ForeName>
<Initials>SH</Initials>
<AffiliationInfo><Affiliation>Max Planck Institute for Infection Biology, Department of Immunology, Schumannstrasse 21-22, 10117 Berlin, Germany. kaufmann@mpiib-berlin.mpg.de</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>McMichael</LastName>
<ForeName>Andrew J</ForeName>
<Initials>AJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Nat Med</MedlineTA>
<NlmUniqueID>9502015</NlmUniqueID>
<ISSNLinking>1078-8956</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016915">AIDS Vaccines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D032581">Tuberculosis Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nat Med. 2005 May;11(5):578</RefSource>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D016915" MajorTopicYN="Y">AIDS Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000163" MajorTopicYN="N">Acquired Immunodeficiency Syndrome</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
<QualifierName UI="Q000331" MajorTopicYN="N">legislation & jurisprudence</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009163" MajorTopicYN="N">Mycobacterium bovis</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014376" MajorTopicYN="N">Tuberculosis</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D032581" MajorTopicYN="Y">Tuberculosis Vaccines</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>125</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>4</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>7</Month>
<Day>8</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>4</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15812488</ArticleId>
<ArticleId IdType="pii">nm1221</ArticleId>
<ArticleId IdType="doi">10.1038/nm1221</ArticleId>
<ArticleId IdType="pmc">PMC7095892</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Clin Immunol. 2004 Jan;110(1):2-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14986673</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2002 Aug;8(8):843-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12141971</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2000 Jan;181(1):406</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10608800</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>AIDS. 2003 Jul 4;17(10):1513-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12824789</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>JAMA. 1994 Mar 2;271(9):698-702</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8309034</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Immunol. 2004 Mar;5(3):233-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14985706</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2000 Sep 28;407(6803):523-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11029005</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Bacteriol. 2002 Dec;184(24):6760-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12446625</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 1996 Aug;2(8):893-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8705859</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Invest. 2001 Feb;107(3):341-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11160158</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Microbiol. 2003 Dec;1(3):181-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15035022</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Immunol. 2001 Oct;1(1):20-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11905811</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Vaccine. 2002 May 6;20(15):1945-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11983251</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2002 Jan 17;415(6869):331-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11797011</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2003 Jan 15;187(2):315-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12552458</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4144-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12644702</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1999 Jan;73(1):797-800</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9847391</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 1991 Jun 6;351(6326):479-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2046750</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Genet. 2001 Dec;2(12):967-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11733749</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Infect Immun. 2001 Feb;69(2):1142-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11160012</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 1999 Nov 4;402(6757):79-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10573420</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2004 Sep;10(9):935-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15300244</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2002 May 2;417(6884):95-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11986671</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Immunol. 2004 Sep;5(9):927-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15300249</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2003 May;9(5):533-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12692540</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2004 Mar 26;303(5666):2019-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15044802</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Infect Immun. 2001 Apr;69(4):2714-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11254639</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Mar;78(6):3140-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14990733</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Tissue Antigens. 2004 Sep;64(3):251-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15304005</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2001 Apr 6;292(5514):69-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11393868</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Trends Microbiol. 2002 Jan;10(1):45-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11755085</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Eur J Immunol. 1996 Sep;26(9):2062-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8814247</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Infect Immun. 1992 Apr;60(4):1263-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1312514</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2004 Mar;10(3):229-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14991039</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2000 Oct;6(10):1140-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11017146</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13853-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11095745</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2002 May 10;296(2):338-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12069532</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 1998 Apr;4(4):397-402</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9546783</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet Infect Dis. 2004 Dec;4(12):761-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15567126</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Exp Med. 2004 Dec 6;200(11):1455-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15583017</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2001 Jul 12;412(6843):190-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11449276</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 1998 Jun 4;393(6684):474-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9624003</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12617573</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2002 Jun 22;359(9324):2177-87</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12090997</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Mol Microbiol. 2001 Jul;41(1):179-87</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11454210</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Infect Immun. 2004 Nov;72(11):6622-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15501795</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 1996 Mar;2(3):334-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8612234</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 1998 Jun 18;393(6686):705-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9641684</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1500-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15602129</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2004 Dec;10(12):1359-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15568033</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 1999 May 28;284(5419):1520-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10348738</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Vaccine. 2005 May 31;23(29):3753-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15893612</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Exp Med. 2004 Sep 20;200(6):749-59</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15365096</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2000 Sep;6(9):955-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10973302</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 1998 May;4(5 Suppl):515-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9585202</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 2004 Jun 15;172(12):7618-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15187142</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Infect Immun. 2001 May;69(5):2773-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11292688</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5299-304</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9560270</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2002 Jan 17;415(6869):335-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11797012</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Infect Immun. 2001 Feb;69(2):681-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11159955</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Exp Med. 1993 Dec 1;178(6):2249-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7504064</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2002 Mar 22;295(5563):2255-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11910108</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):934-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8570663</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10685-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15243159</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Vaccine. 1994 Aug;12(11):1032-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7975844</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7534-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11416222</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Vaccine. 1998 Mar;16(5):439-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9491498</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2000 Jun 9;288(5472):1789-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10846155</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell. 1996 Aug 9;86(3):367-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8756719</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr HIV Res. 2004 Jul;2(3):223-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15279586</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Exp Med. 1993 Dec 1;178(6):2243-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8245795</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15131-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14627745</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Infect Immun. 2004 Sep;72(9):5315-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15322028</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2004 May 28;304(5675):1318-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15166379</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>AIDS. 2001 Feb;15 Suppl 1:S10-1</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11293384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Annu Rev Immunol. 1997;15:271-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9143689</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S353-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2652252</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Immunol. 2003 Oct;4(10):949-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14515128</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 1999 Jul 15;400(6741):269-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10421369</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Microbiol. 2004 Dec;2(12):946-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15550940</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2004 Mar;10(3):275-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14966520</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2000 Aug 17;406(6797):735-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10963599</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Immunol. 2004 Aug;4(8):630-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15286729</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2000 Oct 20;290(5491):486-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11039923</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Exp Immunol. 2001 Feb;123(2):264-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11207657</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2002 Nov 28;420(6914):434-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12459786</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2004 May 28;304(5675):1314-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15166378</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Annu Rev Immunol. 2002;20:581-620</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11861613</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Immunol. 2003 Oct;4(10):939-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14515123</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Exp Med. 2003 Sep 1;198(5):705-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12953092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 1999 Oct 14;341(16):1174-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10519895</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 1999 Dec 4;354(9194):1932-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10622295</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Immunol. 2003 Oct;4(10):1009-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14502286</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Invest. 1998 Nov 1;102(9):1758-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9802890</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 2002 Apr 1;168(7):3477-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11907108</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2004 Nov;10(11):1240-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15502839</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Exp Immunol. 2000 Jan;119(1):92-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10606969</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2272-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8637862</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2003 Jun;9(6):729-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12766765</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 Apr 11;300(5617):337-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690201</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 2002 Nov 1;169(9):5347-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12391256</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Annu Rev Med. 2002;53:557-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11818490</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Infect Immun. 2004 Nov;72(11):6471-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15501778</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Pharm Biotechnol. 2003 Feb;4(1):69-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12570683</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2004 Mar;10(3):221-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14991035</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Exp Med. 2003 Dec 15;198(12):1909-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14676302</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 1992 Dec 18;258(5090):1938-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1470917</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Pathol. 2004 Oct;204(2):217-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15376257</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2002 May 24;296(5572):1439-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12029127</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002805 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002805 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:15812488 |texte= Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:15812488" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |